Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew A Lardy

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Chemical Information and Modeling|April 19, 2012
Building a three-dimensional model of CYP2C9 inhibition using the Autocorrelator: an autonomous model generatorMatthew A Lardy, Laurie Lebrun, Drew Bullard, et al.
Journal of Chemical Information and Modeling|March 15, 2008
Hydra: a self regenerating high performance computing grid for drug discoveryDrew Bullard, Alberto Gobbi, Matthew A Lardy, et al.
Bioorganic & Medicinal Chemistry|December 24, 2013
Synthesis/biological evaluation of hydroxamic acids and their prodrugs as inhibitors for Botulinum neurotoxin A light chainHajime Seki, Sabine Pellett, Peter Silhár, et al.
ACS Medicinal Chemistry Letters|April 9, 2013
The C-terminus of Botulinum A Protease Has Profound and Unanticipated Kinetic Consequences Upon the Catalytic CleftPeter Silhár, Matthew A Lardy, Mark S Hixon, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Chemical Information and Modeling|April 19, 2012
Building a three-dimensional model of CYP2C9 inhibition using the Autocorrelator: an autonomous model generatorMatthew A Lardy, Laurie Lebrun, Drew Bullard, et al.
Journal of Chemical Information and Modeling|March 15, 2008
Hydra: a self regenerating high performance computing grid for drug discoveryDrew Bullard, Alberto Gobbi, Matthew A Lardy, et al.
Bioorganic & Medicinal Chemistry|December 24, 2013
Synthesis/biological evaluation of hydroxamic acids and their prodrugs as inhibitors for Botulinum neurotoxin A light chainHajime Seki, Sabine Pellett, Peter Silhár, et al.
ACS Medicinal Chemistry Letters|April 9, 2013
The C-terminus of Botulinum A Protease Has Profound and Unanticipated Kinetic Consequences Upon the Catalytic CleftPeter Silhár, Matthew A Lardy, Mark S Hixon, et al.
Pageof 1